• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

CureVac begins Phase I Omicron-targeting Covid-19 vaccine trial

cafead

Administrator
Staff member
  • cafead   Aug 19, 2022 at 10:42: AM
via CureVac has initiated the Phase I clinical trial of the modified Covid-19 messenger ribonucleic acid (mRNA) vaccine candidate CV0501, to be given as a booster following the initial vaccine series.

article source
 

<